Currently, one closed-loop system, the Medtronic MiniMed 670G, is in commercial use in the United States, but randomized trials are needed to assess its efficacy and safety. 8 Such a system, which ...

we assigned patients with type 1 diabetes in a 1:1 ratio to use an open-source AID system or a sensor-augmented insulin pump (control). The patients included both children (defined as 7 to 15 ...

Switching to the Minimed 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control. Acta Diabetol.

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia ... following its prior clearance for type 1 diabetes. The Control-IQ+ algorithm enables AID in conjunction ...

The system integrates data from a continuous glucose monitoring (CGM) device, a control algorithm ... new advancements to people living with type 1 diabetes.” MPR, a trusted source of medical ...